Preferred Label : Bone Remodeling Pathway;
NCIt synonyms : Bone Remodelling Pathway;
NCIt related terms : Bone Remodelling;
Alternative definition : BIOCARTA: Bone density and structure is maintained through a balance of bone resorption
by osteoclasts and bone deposition by osteoblasts. The combination of simultaneous
resorption and deposition creates continual remodeling of bone while excess osteoclast
activity leads to an imbalance and a loss of bone density, causing osteoporosis. RANK
(receptor activator of NF-kB ligand) is a receptor in the TNF receptor gene family
that is involved in osteoclast differentiation. RANK-ligand, also called osteoprotegerin-ligand,
binds to RANK, induces receptor dimerization, and activates downstream signaling.
Osteoprotegerin is a decoy receptor for RANK-ligand that suppresses osteoclast activity
and bone remodeling, helping to maintain balanced bone remodeling. RANK-ligand and
osteoprotegerin are produced by osteoblasts and some factors regulate osteoclast activity
indirectly through their action on the expression of these factors by osteoblasts.
Binding of RANK-ligand to RANK activates signaling through TRAF-6. TRAF-6 induces
several downstream signaling events, including activation of NF-kB, c-Fos and the
kinase JNK1. Jnk-1 activation contributes to fos activation by RANK-ligand and may
be involved in the modulation of RANK-ligand by other factors such as estrogen. Mice
lacking the c-Fos gene have overly dense bone and decreased bone resorption due to
reduced osteoclast differentiation, indicating that c-Fos is an important mediator
of osteoclast differentiation. One of the results of c-Fos induction is transcriptional
activation of interferon-beta. Interferon-beta binds to its receptor on neighboring
osteoclast precursor cells to block RANK-ligand signaling and down-regulate c-Fos
expression, inhibiting further osteoclast differentiation. Mice lacking interferon-beta
or the interferon-beta receptor lose bone due to uncontrolled osteoclast activity,
demonstrating the importance of this mechanism in vivo. Interferon-beta signaling
could be used as a mechanism to prevent osteoporosis and other conditions involving
excessive osteoclast resorption of bone. (This definition may be outdated - see the
DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_ranklPathway;
Origin ID : C39212;
UMLS CUI : C1521997;
- Automatic exact mappings (from CISMeF team)
- Semantic type(s)
- has_gene_product_element
- pathway_has_gene_element